Effect of Testosterone Replacement on Response to Sildenafil Citrate in Men With Erectile Dysfunction: A Parallel, Randomized Trial

Annals of Internal Medicine

Volumn 157, Issue 10, 2012, Pages 681-691

  Spitzer, Matthew ^a   Basaria, Shehzad ^a   Travison, Thomas G ^a   Davda, Maithili N ^a   Paley, Amanda ^a   Cohen, Beth ^a   Mazer, Norman A ^c   Knapp, Philip E ^a   Hanka, Samson ^a   Lakshman, Kishore M ^a   Ulloor, Jagadish ^a   Zhang, Anqi ^a   Orwoll, Katie ^a   Eder, Richard ^a   Collins, Lauren ^a   Mohammed, Nurahmed ^a   Rosen, Raymond C ^b   DeRogatis, Leonard ^d   Bhasin, Shalender ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SILDENAFIL; TESTOSTERONE;

ADULT; ADVERSE OUTCOME; AGED; ANDROGEN THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG SAFETY; ENDOCRINE DISEASE; ERECTILE DYSFUNCTION; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HUMAN; INFECTION; INTERNATIONAL INDEX OF ERECTILE FUNCTION; LIVER DISEASE; LYMPHATIC SYSTEM DISEASE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; METABOLIC DISORDER; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; OBESITY; PENIS ERECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SKIN DISEASE; TESTOSTERONE BLOOD LEVEL; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; UROGENITAL TRACT DISEASE;

EID: 84872546745     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-157-10-201211200-00004     Document Type: Article

References (51)

1. Montorsi F, Adaikan G, Becher E, Giuliano F, Khoury S, Lue TF, et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2010;7:3572-88. [PMID: 21040491]
2. Fisher WA, Eardley I, McCabe M, Sand M. Erectile dysfunction (ED) is a shared sexual concern of couples I: couple conceptions of ED. J Sex Med. 2009; 6:2746-60. [PMID: 19694926]
3. Lindau ST, Schumm LP, Laumann EO, Levinson W, O'Muircheartaigh CA, Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med. 2007;357:762-74. [PMID: 17715410]
4. Seftel AD, Sun P, Swindle R. The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J Urol. 2004; 171:2341-5. [PMID: 15126817]
5. Dong JY, Zhang YH, Qin LQ. Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol. 2011;58: 1378-85. [PMID: 21920268]
6. Qaseem A, Snow V, Denberg TD, Casey DE Jr, Forciea MA, Owens DK, et al; Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Hormonal testing and pharmacologic treatment of erectile dysfunction: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2009;151:639-49. [PMID: 19884625]
7. Alexander GM, Sherwin BB. The association between testosterone, sexual arousal, and selective attention for erotic stimuli in men. Horm Behav. 1991;25: 367-81. [PMID: 1937428]
8. Burris AS, Banks SM, Carter CS, Davidson JM, Sherins RJ. A long-term, prospective study of the physiologic and behavioral effects of hormone replacement in untreated hypogonadal men. J Androl. 1992;13:297-304. [PMID: 1399830]
9. Bhasin S, Enzlin P, Coviello A, Basson R. Sexual dysfunction in men and women with endocrine disorders. Lancet. 2007;369:597-611. [PMID: 17307107]
10. Traish AM. Androgens play a pivotal role in maintaining penile tissue architecture and erection: a review. J Androl. 2009;30:363-9. [PMID: 18802199]
11. Traish AM, Park K, Dhir V, Kim NN, Moreland RB, Goldstein I. Effects of castration and androgen replacement on erectile function in a rabbit model. Endocrinology. 1999;140:1861-8. [PMID: 10098525]
12. Mills TM, Lewis RW, Stopper VS. Androgenic maintenance of inflow and veno-occlusion during erection in the rat. Biol Reprod. 1998;59:1413-8. [PMID: 9828186]
13. Aversa A, Isidori AM, Spera G, Lenzi A, Fabbri A. Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol (Oxf). 2003;58:632-8. [PMID: 12699447]
14. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol. 2004;172: 658-63. [PMID: 15247755]
15. Buvat J, Montorsi F, Maggi M, Porst H, Kaipia A, Colson MH, et al. Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study). J Sex Med. 2011;8:284-93. [PMID: 20704642]
16. Reilly CM, Zamorano P, Stopper VS, Mills TM. Androgenic regulation of NO availability in rat penile erection. J Androl. 1997;18:110-5. [PMID: 9154504]
17. Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, et al; International Society of Andrology (ISA). Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl. 2009;30:1-9. [PMID: 18772485]
18. Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, et al; European Association of Urology. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol. 2010;57: 804-14. [PMID: 20189712]
19. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, et al; Task Force, Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:2536-59. [PMID: 20525905]
20. Guay AT, Spark RF, Bansal S, Cunningham GR, Goodman NF, Nankin HR, et al; American Association of Clinical Endocrinologists Male Sexual Dysfunction Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: a couple's problem-2003 update. Endocr Pract. 2003;9:77-95. [PMID: 12917096]
21. Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS). J Sex Med. 2011;8:3204-13. [PMID: 21834870]
22. Tsertsvadze A, Fink HA, Yazdi F, MacDonald R, Bella AJ, Ansari MT, et al. Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis. Ann Intern Med. 2009;151: 650-61. [PMID: 19884626]
23. Bhasin S, Pencina M, Jasuja GK, Travison TG, Coviello A, Orwoll E, et al. Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. J Clin Endocrinol Metab. 2011;96:2430-9. [PMID: 21697255]
24. Steidle C, Schwartz S, Jacoby K, Sebree T, Smith T, Bachand R; North American AA2500 T Gel Study Group. AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. J Clin Endocrinol Metab. 2003;88:2673-81. [PMID: 12788872]
25. Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM, et al. Adverse events associated with testosterone administration. N Engl J Med. 2010;363:109-22. [PMID: 20592293]
26. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822-30. [PMID: 9187685]
27. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med. 1998;338:1397-404. [PMID: 9580646]
28. Padma-Nathan H, McMurray JG, Pullman WE, Whitaker JS, Saoud JB, Ferguson KM, et al; IC351 On-Demand Dosing Study Group. On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction. Int J Impot Res. 2001;13:2-9. [PMID: 11313831]
29. Rosen RC, Catania J, Pollack L, Althof S, O'Leary M, Seftel AD. Male Sexual Health Questionnaire (MSHQ): scale development and psychometric validation. Urology. 2004;64:777-82. [PMID: 15491719]
30. Wagner TH, Patrick DL, McKenna SP, Froese PS. Cross-cultural development of a quality of life measure for men with erection difficulties. Qual Life Res. 1996;5:443-9. [PMID: 8840824]
31. Paige NM, Hays RD, Litwin MS, Rajfer J, Shapiro MF. Improvement in emotional well-being and relationships of users of sildenafil. J Urol. 2001;166: 1774-8. [PMID: 11586222]
32. Schag CA, Ganz PA, Heinrich RL. CAncer Rehabilitation Evaluation System-short form (CARES-SF). A cancer specific rehabilitation and quality of life instrument. Cancer. 1991;68:1406-13. [PMID: 1873793]
33. Derogatis LR, Palmer A. The Derogatis Affects Balance Scale. In: Zalaquett CP, Wood RJ, eds. Evaluating Stress: A Book of Resources, Volume 2. Blue Ridge Summit, PA: Scarecrow Pr; 1998:89-117.
34. Dupuy HJ. The Psychological General Well-Being (PGWB) Index. In: Wenger NK, Mattson ME, Furberg CD, Elinson J, eds. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York: Le Jacq Pub; 1984:170-83.
35. Bhasin S, Travison TG, Storer TW, Lakshman K, Kaushik M, Mazer NA, et al. Effect of testosterone supplementation with and without a dual 5_-reductase inhibitor on fat-free mass in men with suppressed testosterone production: a randomized controlled trial. JAMA. 2012;307:931-9. [PMID: 22396515]
36. Choi HH, Gray PB, Storer TW, Calof OM, Woodhouse L, Singh AB, et al. Effects of testosterone replacement in human immunodeficiency virusinfected women with weight loss. J Clin Endocrinol Metab. 2005;90:1531-41. [PMID: 15613414]
37. Sinha-Hikim I, Arver S, Beall G, Shen R, Guerrero M, Sattler F, et al. The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virusinfected women. J Clin Endocrinol Metab. 1998;83:1312-8. [PMID: 9543161]
38. Rosen RC, Cappelleri JC, Gendrano N 3rd. The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res. 2002;14: 226-44. [PMID: 12152111]
39. Rosen RC, Allen KR, Ni X, Araujo AB. Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. Eur Urol. 2011;60:1010-6. [PMID: 21855209]
40. van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res. 2007;16:219-42. [PMID: 17621469]
41. Li KH, Meng XL, Raghunathan TE, Rubin DB. Significance levels from repeated p-values with multiply-imputed data. Statistica Sinica. 1991;1:65-92.
42. Meng XL, Rubin DB. Performing likelihood ratio tests with multiplyimputed data sets. Biometrika. 1992;79:103-11.
43. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121-30. [PMID: 3719049]
44. Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: Springer; 2009.
45. Montorsi F, McDermott TE, Morgan R, Olsson A, Schultz A, Kirkeby HJ, et al. Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologies. Urology. 1999;53:1011-8. [PMID: 10223498]
46. Mills TM, Dai Y, Stopper VS, Lewis RW. Androgenic maintenance of the erectile response in the rat. Steroids. 1999;64:605-9. [PMID: 10503716]
47. Cavallini G, Caracciolo S, Vitali G, Modenini F, Biagiotti G. Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging. Urology. 2004;63:641-6. [PMID: 15072869]
48. Carosa E, Martini P, Brandetti F, Di Stasi SM, Lombardo F, Lenzi A, et al. Type V phosphodiesterase inhibitor treatments for erectile dysfunction increase testosterone levels. Clin Endocrinol (Oxf). 2004;61:382-6. [PMID: 15355456]
49. Andric SA, Janjic MM, Stojkov NJ, Kostic TS. Sildenafil treatment in vivo stimulates Leydig cell steroidogenesis via the cAMP/cGMP signaling pathway. Am J Physiol Endocrinol Metab. 2010;299:E544-50. [PMID: 20663985]
50. Janjic MM, Stojkov NJ, Bjelic MM, Mihajlovic AI, Andric SA, Kostic TS. Transient rise of serum testosterone level after single sildenafil treatment of adult male rats. J Sex Med. 2012. [PMID: 22429315]
51. Buena F, Swerdloff RS, Steiner BS, Lutchmansingh P, Peterson MA, Pandian MR, et al. Sexual function does not change when serum testosterone levels are pharmacologically varied within the normal male range. Fertil Steril. 1993; 59:1118-23. [PMID: 8486184]